Call for research funding to prevent pregnancy complications
Posted on: Tuesday, 4 October 2005, 14:24 CDT
State representatives and senators got a call for more research funding to prevent pregnancy complications from a Yale School of Medicine researcher at the 7th annual Women In Government regional conference on September 28.
The incidence of preterm birth and low birthweight infants are the most pressing obstetrical issues today, in addition to the malpractice crisis, according to Michael Paidas, M.D., associate professor and director of The Program for Thrombosis and Hemostasis in Women's Health in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine.
Paidas' talk included strategies for diagnosis, management and prevention of adverse pregnancy outcomes. He pointed out the important role of risk assessment with fetal fibronectin and cervical length as strong predictors of preterm birth. He also outlined what legislators can do to improve overall pregnancy outcomes and long-term women's health.
"We know now that complicated pregnancies have long-term consequences for women's health, particularly cardiovascular disease," said Paidas, one of 60 national researchers, health care professionals, state representatives and senators attending the conference. "We need more federal funding to understand this complex set of diseases in order to prevent poor pregnancy outcomes and treat complicated pregnancies."
Paidas added, "The cost of caring for premature infants is over $15 billion in the newborn period alone. The malpractice crisis is limiting the number of physician scientists dedicated to reproductive medicine, and drastically reducing the number of obstetricians to deliver care to our patients."
Women In Government President Susan Crosby said, "Women In Government is excited to bring this important issue to the attention of our legislative members in the Eastern Region. We look forward to continuing our work on pregnancy management and pre-term delivery in the future."
On the World Wide Web:
Related Articles
- Women's Sexual Health Company Changes Name in Preparation for Market Entry
- Women's Heart Health a Critical Focus at Northwestern Memorial's Bluhm Cardiovascular Institute
- What You Need to Know About Women's Oral Health
- BioSante Pharmaceuticals to Present LibiGel(R) at International Society for the Study of Women's Sexual Health (ISSWSH) Annual Meeting
- Mayor Nickels Proclaims October 12 Women's Heart Health Day
- Sunnybrook and Women's College Health Sciences Centre Purchase Avega's Alliance Decision Support, Alliance Financial Management, and myAlliance Portal
- BioSante Pharmaceuticals Presents Bio-E-Gel(TM) Data at The International Society for the Study of Women's Sexual Health Annual Meeting
- BioSante Pharmaceuticals to Present at International Society for the Study of Women's Sexual Health and Sachs Biotech Conferences
- APTA Attends Briefing on Women and Health Care
- Decision Making in Health and Medicine. Integrating Evidence and Values
User Comments (0)

RSS Feeds